WAY-200070, >= 98%( HPLC )

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

WAY-200070, a selective estrogen receptor-beta (ER-β) agonist, may be used in estrogen receptor signaling research along with other ERβ agonists [diarylpropionitrile (DPN)] and antagonist to help identify and differentiate the functions of estrogen receptor-beta(s) (ER-β) involved in processes such as regulation of the physiology of the endocrine pancreas; modulation of visceral pain; and stress response. WAY-200070 may be used to help establish that an observed physiological or cell signaling response is ER-β-dependent, especially versus ERα.

Biochem/physiol Actions

Potent, selective estrogen receptor-beta (ER-β) agonist (IC₅₀ 2.3 nM vs 155 nM for ER-α) with anxiolytic-like and antidepressant-like effects.

Features and Benefits

This compound was developed by Wyeth. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

General description

WAY-200070 is a potent, selective estrogen receptor-beta (ER-β) agonist (IC50 2.3 nM vs. 155 nM for ER-α) with anxiolytic-like and antidepressant-like effects.

Packaging

5, 25 mg in glass bottle